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 The ability to test large arrays of cell and biomaterial combinations in 3D 
environments is still rather limited in the context of tissue engineering and 
regenerative medicine. This limitation can be generally addressed by employ-
ing highly automated and reproducible methodologies. This study reports on 
the development of a highly versatile and upscalable method based on additive 
manufacturing for the fabrication of arrays of scaffolds, which are enclosed 
into individualized perfusion chambers. Devices containing eight scaffolds and 
their corresponding bioreactor chambers are simultaneously fabricated utiliz-
ing a dual extrusion additive manufacturing system. To demonstrate the versa-
tility of the concept, the scaffolds, while enclosed into the device, are subse-
quently surface-coated with a biomimetic calcium phosphate layer by perfusion 
with simulated body fl uid solution. 96 scaffolds are simultaneously seeded and 
cultured with human osteoblasts under highly controlled bidirectional perfu-
sion dynamic conditions over 4 weeks. Both coated and noncoated resulting 
scaffolds show homogeneous cell distribution and high cell viability through-
out the 4 weeks culture period and CaP-coated scaffolds result in a signifi cantly 
increased cell number. The methodology developed in this work exemplifi es 
the applicability of additive manufacturing as a tool for further automation of 
studies in the fi eld of tissue engineering and regenerative medicine. 
in vitro, and provide mechanical sup-
port and space maintenance to allow the 
formation of new tissue and appropriate 
vascularization in vivo. Further, these scaf-
folds with a tailored composition/architec-
ture when combined with cells of interest 
and any necessary biochemical and phys-
ical cues, are essential for the successful 
development of tissue-engineered con-
structs (TEC) with desirable in vivo prop-
erties. [ 2 ] This is generally achieved through 
an extensive and time consuming optimi-
zation process. 
 The utilization of upscalable and 
modular bioreactors enables the culture 
of large numbers of constructs under 
automated and highly controlled condi-
tions simultaneously. This methodology 
is widely utilized in applications such 
as high throughput screening (HTS) for 
screening compounds for drug discovery 
purposes [ 3 ] and has been also proposed for 
screening 3D structures for tissue engi-
neering applications. [ 4 ] However in the 
majority of these existing devices, several 
drawbacks remain when screening bio-
materials and more specifi cally 3D scaffolds. One of the main 
limitations is the mostly 2D nature of the protocols utilized 
for investigating cellular response and behavior, which may 
not necessarily be relevant in 3D environments. [ 5 ] Fluid diffu-
sion and associated nutrient and oxygen supply within a given 
construct along with cell-material and cell–cell interactions are 
also crucial parameters, which greatly infl uence in vitro cel-
lular maturation. These aspects are particularly critical when 
considering the use of large dimension constructs close to that 
required in the target application and when the cell culture is 
performed statically. Flow perfusion bioreactors are tradition-
ally utilized to circumvent these aforementioned issues in scaf-
folds with signifi cantly larger dimensions. Perfusion improves 
nutrient supply and distribution and therefore avoids cell death 
in the most central regions of the scaffolds. [ 6 ] However, the lack 
of versatility in current perfusion bioreactor systems does not 
permit facile design modifi cations such as incorporating addi-
tional culture chambers and it does not provide the fl exibility 
to utilize scaffolds of various sizes without entirely redesigning 
the bioreactor system. In some fl ow perfusion bioreactors, sub-
optimal fl uid fl ow distribution allows media to fl ow around the 
scaffold but does not necessarily perfuse through the construct 
 1.  Introduction 
 Tissue engineering is based on the combination of cells and 3D 
porous scaffolds to facilitate the replacement and regeneration 
of damaged tissues.  [ 1 ] As such, scaffolds should enable both the 
maintenance of suffi cient oxygen diffusion and nutrient supply 
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when the scaffold dimension is signifi cantly different to that 
of the bioreactor chamber. [ 6j ] These design limitations greatly 
impede the fabrication and testing of large arrays of scaffolds 
with multiple characteristics (such as architecture, dimensions, 
shape, etc.) in an upscalable manner. 
 Additive manufacturing technologies such as fused deposi-
tion modeling, offer the possibility to rapidly generate arrays of 
porous 3D constructs with different shapes and architectures 
in a highly controlled and reproducible manner. [ 7 ] In a previous 
report, [ 8 ] we utilized this technology for fabricating an anatomi-
cally relevant device comprising a porous scaffold replica of an 
ovine tibia around which a bioreactor chamber of similar shape 
was simultaneously built. We hypothesized that this concept 
could be further utilized in large-scale cell culture studies while 
circumventing the aforementioned issues associated with the 
use of traditional bioreactors. This would enable to reproduc-
ibly manufacture arrays of 3D scaffolds and permit their subse-
quent in vitro culture in a bioreactor chamber in large batches, 
hence accelerating their characterization. For this purpose, 
we developed and tested a modular bioreactor device, which 
was fabricated by dual extrusion fused deposition modeling. 
This proof of concept study reports on the design, fl uid fl ow 
optimization, fabrication, and in vitro characterization of the 
device demonstrating an ability to be further utilized in wide 
and complex tissue engineering studies (potentially even high 
throughput strategies). 
 2.  Results and Discussion 
 The present study demonstrates that additive manufacturing 
can be applied to the fabrication of complex cell culture devices 
for generating wide arrays of large 3D tissue engineered con-
structs under highly controlled conditions. As the design and 
fl uid fl ow optimization are performed at the numerical level 
and then carried out by the same single automated equip-
ment, the integration of additive manufacturing in large 
culture/screening studies demonstrates the advantage of gen-
erating arrays of 3D scaffolds in a highly reproducible manner 
while also facilitating possible design modifi cations (scaffold 
number, dimension and architecture). The highly 3D nature of 
the device represents a signifi cant advancement in the fi eld as 
most large-scale culture systems (in particular, HTS systems) 
tend to have reduced three-dimensionality and/or in vitro cell 
culture is performed under static conditions. [ 9 ] Also, the auto-
mation of the scaffold fabrication along with the bidirectional 
perfusion enables the systematic assessment of the scaffold 
performance in a more standardized and highly controlled 
manner and at an effective cost and speed. It also reduces 
variations inherent to manual cell culture, such as differences 
in manual cell seeding effi cacy, potential contamination due 
to frequent media change, as well as variability in volume of 
media utilized, which can affect oxygen diffusion and therefore 
result in disparities within samples. Moreover, most bioreac-
tors can test only a few samples at any one time and therefore 
systematic assessments involving large number of specimens 
are highly time consuming and labor-intensive. [ 10 ] This is in 
contrast to the technology proposed in the present study, which 
is unprecedented in the literature as it was capable of testing 
a large number of highly 3D samples under bidirectional per-
fusion. Indeed, even in a simplifi ed 4 × 2 confi guration, 96 
3D scaffolds contained in 12 separated culture devices were 
simultaneously cultured demonstrating the upscalability of the 
developed device. 
 2.1.  Fluid Flow Modeling 
 Fluid fl ow modeling was used to optimize the design of the 
individual culture chambers in the developed device. The 
main requirements considered during this optimization were: 
(1) homogeneous fl uid velocities throughout the entire scaffold; 
and (2) the elimination of any stagnant fl uid regions. Homoge-
neous fl uid distribution ensures a constant and uniform supply 
of nutrients and oxygen within the construct. When similar 
culture conditions are achieved throughout the scaffolds, high 
reproducibility can be achieved. To this end, a number of dif-
ferent confi gurations of the culture chamber and geometry of 
the top outlet ( Figure  1 ) were tested. 
 The geometry of the top outlet was shown to signifi cantly 
impact on the fl ow pattern as demonstrated in Figure  1 a,b. 
Indeed an open outlet (Figure  1 b) was found to signifi cantly 
reduce the formation of both low and high velocity zones in 
the upper portion of the scaffold when compared with a closed 
outlet confi guration (Figure  1 a). 
 Taking into consideration results obtained in a previous 
study, [ 11 ] the design of the chamber was modifi ed to prevent the 
formation of regions with heterogeneous fl uid velocity located 
at the base of the scaffold. To this end, a porous acrylonitrile 
butadiene styrene (ABS) structure supporting the PLA scaffold 
was inserted at the bottom of the chamber. This resulted in posi-
tioning the scaffold away from the high velocity regions (repre-
sented in yellow and red and highlighted by the black arrows in 
Figure  1 ) located in the vicinity of the inlet/outlet. The cham-
bers were chamfered 2 mm with an angle of 45° (Figure  1 c) 
to eliminate low fl uid velocity regions (white arrows in 
Figure  1 a,b) as demonstrated in our previous work. [ 8 ] This con-
fi guration combining the ABS support structure and the cham-
fered chambers maintained a homogeneous fl uid fl ow velocity 
throughout the scaffold ranging from 10% to 15% of the initial 
fl ow rate (Figure  1 c). At the inlet of each individual chamber, 
the fl ow rate was 0.1 mL min –1 and therefore, the fl ow rate 
in the scaffold ranged from 0.01–0.015 mL min –1 (Figure  1 c), 
which is in agreement with optimal fl ow rates reported in other 
studies. [ 6a , 12 ] This optimized design of an individual bioreactor 
chamber was then utilized to fabricate the upscalable device. 
 This study demonstrates the proof of principle of this plat-
form into much more complex devices. Our future aim is to 
generate more elaborate designs comprising multiple condi-
tions within one single device/setup. Similarly to what can be 
found in the bibliography, these multiple varying conditions 
may in the future consist of gradients/arrays of multiple rea-
gent concentrations [ 13 ] or multiple levels of hydrodynamic 
shear levels [ 14 ] generated by minifl uidic channel networks as 
well as multiple scaffold material compositions by employing 
multimaterial 3D printers, multiple cellular contents, among 
other variables. Such 3D cell culture platforms would be highly 
advantageous for applications in high throughput screening of 
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drugs in which a large number of cells is needed to perform 
statistically relevant gene and protein analysis. 
 2.2.  Design, Fabrication, and Postprocessing of the Device 
 3Ds Max software was used to design a multichamber device, 
which could simultaneously accommodate eight scaffolds 
( Figure  2 a). Figure  2 a shows the different elements utilized to 
create the numerical 3D model. The base of the device inte-
grated a network of 1-mm wide fl uidic channels connecting 
each of the eight culture chambers to one single medium 
inlet/outlet (Figure  2 a1–a2). Based on the fl uid fl ow modeling 
analysis, the bottom of each chamber was chamfered by 2 mm 
along an angle of 45° (Figure  2 a2) onto which, a 1-mm thick 
porous ABS structure (Figure  2 a3) was added to support the 
PLA scaffold represented in green in Figure  2 a4. Each scaffold 
was surrounded by a 10-mm wide square chamber with 1-mm 
thick walls and positioned at a distance of 1 mm from the sides 
of the scaffolds (Figure  2 a5). This chamber was 18 mm high 
to create a reservoir for the subsequent cell culture as shown 
in Figure  2 a6. Two pyramidal structures were then placed over 
each group of four chambers to fully enclose the device. The 
fi nal model of the device (Figure  2 a7) was saved as an STL fi le, 
converted to G-Code using RepRap and ReplicatorG software 
and fi nally prototyped in a Makerbot dual extrusion fused depo-
sition prototyping machine (Figure  2 b1,b2) (Video S1, Sup-
porting Information). The time necessary for fabricating each 
device was 40 min. 
 As some open porosity remained within the outer wall of 
the bioreactor chamber, a surface treatment with an ABS solu-
tion was used in order to close these pores ensuring that no 
leakage would occur during the subsequent cell culture. As a 
result of this treatment, the outer surfaces of the device became 
smoother and glossier (Figure  2 b5,b6) than nontreated surfaces 
(Figure  2 b3 and  2 b4) due to the elimination of the roughness 
and the interlayer gaps. A more detailed analysis was performed 
using microCT, which confi rmed that most of the porosity 
initially contained in the bioreactor walls was fully closed or 
removed by the ABS treatment ( Figure  3 a1). This analysis 
also demonstrated that the inner walls and the scaffolds were 
not affected by the ABS/acetone treatment (Figure  3 a2–a4) as 
shown by the presence of the original interlayer gaps. 
 The ability to fabricate upscalable culture devices directly 
from numerically designed 3D models by additive manu-
facturing offers signifi cant advantages: it reduces costs and 
human intervention in the fabrication process, while permit-
ting a high degree of control over the size and the architecture 
of the scaffolds. Generally, the fabrication of culture devices 
for culture of large arrays of constructs involves the utilization 
of highly specifi c technologies and equipment, such as clean 
room facilities, spin coaters, mask aligners or micromolding, 
and laser ablation machines, [ 14a , 15 ] which are not necessarily 
commonly available in a research laboratory and moreover, not 
as economically viable as additive manufacturing. Furthermore, 
inherent limitations of these fabrication technologies, such as 
the need to fabricate one or multiple master molds, result in a 
time consuming, expensive and largely manual manufacturing 
process. Devices manufactured in such a way have indeed been 
largely employed in HTS applications [ 6e , 14a ] in order to culture 
simple-shaped cylindrical scaffolds albeit of smaller dimen-
sions than those developed in the present study. Unlike con-
ventional HTS, where insights are mainly provided at a cel-
lular and hence microscopic level, the device developed in this 
study shows the ability to provide further knowledge at a more 
macroscopic/tissue level, hence enabling a more realistic and 
clinically relevant in vitro assessment. Further, a broad range of 
materials can be utilized for fabricating scaffolds and therefore 
contribute to the development of a scaffold materials library. 
The polymer melt-based deposition process permits the fabrica-
tion of objects from a wide array of materials such as aliphatic 
polyesters, polyurethane, etc. 
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 Figure 1.  Fluid fl ow modeling of various device inner architectures. a) Rectangular device with narrow top outlet. b) Rectangular device with wide top 
outlet. c) 2 mm-chamfered chamber with support structure and wide top outlet. White arrows indicate stagnant zones and black arrows indicate high 
velocity zones.
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 To further demonstrate the versatility of our strategy, the PLA 
scaffolds were further coated with a calcium phosphate layer by 
successively fi lling the individual culture chambers with sodium 
hydroxide (NaOH) and hypersaturated simulated body fl uid 
(SBF). Treatment with NaOH increased the hydrophilicity of the 
scaffold by increasing the roughness (as shown by the microporo-
sity in Figure  3 b1,b2) and is also known to increase the density of 
carboxylic acid on the surface of the polymeric struts, which has a 
signifi cant impact on cell adhesion. [ 16 ] The SBF treatment resulted 
in the deposition of biomimetic calcium phosphate crystals. How-
ever, this deposition was not entirely homogenous as agglomera-
tions of CaP spherical particles were found in many locations of 
the scaffold as shown in Figure  3 b3,b4, unlike what was reported 
in another study utilizing a perfusion system for coating scaffolds 
of similar architecture. [ 17 ] The heterogeneity in the CaP coating 
probably originated from the relatively short exposition time and 
the reduced volume of SBF solution utilized, which prevented the 
formation of a continuous CaP layer. The NaOH posttreatment 
was performed to obtain a single phase of CaP as a previous study, 
although performed on a different scaffold, demonstrated that a 
highly soluble CaP phase (brushite) was removed by the gentle 
etching, leaving a unique carbonate hydroxylapatite layer. [ 18 ] These 
two treatments (NaOH etching and CaP coating) demonstrate that 
our device also enables the evaluation of functionalized scaffolds. 
 2.3.  Perfusion Cell Culture 
 Another important aspect of the technology we have developed 
is that it enables the in vitro culture of the scaffold under bidi-
rectional perfusion. The perfusion apparatus was assembled by 
connecting a syringe to the bottom inlet/outlet of each device 
using sterile silicone tubing. To preserve the sterility of the 
device, the top outlets were capped with sterile 0.22 µm fi lters 
( Figure  4 a2). Each silicone tube was then connected to an indi-
vidual syringe placed onto a multisyringe adapter (Figure  4 a1), 
which was mounted into one single syringe pump. The utili-
zation of a culture setup comprising multiple eight chamber 
devices connected to individual syringes mounted onto one 
single syringe pump was chosen in order to show a simple and 
user-friendly scalability of the culture platform; either by var-
ying the number of device chambers, the number of devices/
syringes and/or the number of syringe pumps and therefore 
demonstrate versatility and modularity of the technology plat-
form. The devices were then fi lled with culture medium and the 
scaffolds incubated overnight to enable protein adsorption. The 
following day, cell suspensions were loaded into the devices 
through the silicone tubing and bidirectionally perfused to 
allow homogeneous cell seeding (Video S2, Supporting Infor-
mation). Scaffolds were collected after 24 h, 2 and 4 weeks of 
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 Figure 2.  a) Elements of the device to be prototyped. a1) Base of the device consisting of a lower plate designed with a mini channel network for 
supplying culture medium (red) to the eight culture chambers. a2) The channel network is covered by a perforated layer which defi nes the chamfered 
bottom of the culture chambers as well as a lateral inlet/outlet. a3) Porous support structures positioned over the chamber bottoms. a4) Scaffolds 
positioned over the porous support structures on the bottom of each culture chamber. a5) Walls designed around and in between the scaffolds. 
a6) Walls extended upwards in order to create an upper reservoir over the scaffolds. a7) Two covers designed on the top part of the device to enclose 
the culture chambers. The top of each cover possesses an inlet/outlet for air circulation. b) Fabrication and posttreatment of device. b1) Dual extrusion 
prototyping machine. b2) Close-up view of device being fabricated in the prototyping machine by dual extrusion of ABS (left extruder) and PLA (right 
extruder). b3,b4) Device after rapid prototyping. b5,b6) Device after posttreatment with ABS/acetone solution.
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culture using sterile scissors and tweezers 
according to the method shown in Figure 
 4 b and Video S3 (Supporting Information). 
DNA quantifi cation revealed that the device 
supported cell adhesion and proliferation 
in all types of scaffold as shown in  Figure 
 5 a, although these parameters were signifi -
cantly higher in the CaP-coated specimens. 
Indeed, the DNA content increased four-
fold for the noncoated samples between 
24 h and 4 weeks postseeding, whereas it 
increased 11-fold for the CaP-coated speci-
mens within the same time period. This 
fi nding is supported by several studies, 
which reported a signifi cant increase in the 
cell proliferation on CaP-coated scaffolds. [ 19 ] 
This is explained by the release of Ca 2+ cat-
ions into the culture media from the CaP 
coating, which stimulates cell growth. In our 
previous work, we have demonstrated that 
such CaP layers deposited over the surface 
of polymeric scaffolds are able to enhance in 
vivo bone formation. [ 20 ] The scaffolds were 
stained with 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) to 
assess the cell distribution within the scaf-
fold. Despite low staining effi cacy, at the 
earliest timepoints metabolically active cells 
had homogeneously infi ltrated the scaffolds 
regardless of the surface treatment (coated 
and noncoated) as shown in Figure  5 b. 
This shows that the chamber design was 
effective in homogeneously distributing 
the cells (highlighted by the white arrows) 
throughout the scaffold and hence validates 
the fl uid fl ow simulation analysis. This is 
also in accordance with a previous study [ 8 ] 
employing a similar seeding methodology, 
where we have been able to homogeneously 
seed cells into signifi cantly larger and irregu-
larly shaped scaffolds with no detrimental 
effect on cellular distribution or viability 
throughout the entire scaffold architecture. 
After 4 weeks of culture, the polymeric struts 
of noncoated scaffolds were covered by a 
dense layer of single cells while CaP-coated 
scaffolds were covered by thick sheets of 
cells (in red) bridging multiple struts (high-
lighted by black arrows in Figure  5 b). Scan-
ning electron microscopy (SEM) confi rmed 
the homogeneous cell distribution in both 
scaffold groups and showed that the cells 
gradually covered the polymeric struts and 
were capable of bridging adjacent struts and 
partially fi lling the pores of the scaffold at 4 
weeks postseeding as shown in  Figure  6 . The 
distribution and viability of cells in several 
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 Figure 3.  a) Micro-CT reconstruction of device. a1) 3D reconstruction featuring the smooth 
ABS external wall of the device after posttreatment with an ABS/acetone solution. a2) Cross-
section depicting the structure of the device containing the PLA scaffolds. a3) Morphology of 
the inner surface of the bioreactor chamber which is characteristic of a layer-by-layer deposition 
suggesting that the ABS-acetone posttreatment did not affect the inner wall of the bioreactor 
chamber. a4) Close-up view depicting scaffold architecture and the bottom part of device. 
Arrows indicate sections of mini-fl uidic channels. b) SEM images of scaffolds before (b1,b2) 
and after CaP coating (b3,b4).
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locations of the scaffolds were also assessed by FDA/PI-staining 
combined with confocal laser microscopy (Figure  6 ). Despite 
the presence of some dead cells (red) the majority of cells 
were alive (green) at the 4 weeks culture period showing that 
suffi cient nutrient supply was provided throughout the entire 
scaffold architecture. This was further shown in the semiquan-
titative analysis in which, both coated and noncoated samples 
displayed a percentage of live cells above 85% after 4 weeks of 
dynamic culture ( Table  1 ). 
 3.  Conclusion 
 A unique dynamic cell culture platform based on applying 
additive manufacturing has been developed for simultaneous 
culture of large arrays of scaffolds under highly controlled 
perfusion culture conditions. The versatility and upscalability 
of this concept were assessed by manufacturing a device 
 composed of eight scaffolds placed into individualized cham-
bers, which were further modifi ed by alkaline treatment and by 
simulated body fl uid to generate a biomimetic surface coating. 
The highly scalable nature of the strategy was demonstrated 
by easily culturing 96 scaffolds in one single experiment. The 
scaffolds, regardless of the surface treatment, were successfully 
seeded and cultured with osteoblasts for up to 4 weeks gener-
ating constructs with good viability. The utilization of additive 
manufacturing to build both scaffold and bioreactor in one 
fabrication step provides a new tool for allowing a higher level 
of automation of tissue engineering strategies under 3D and 
highly controlled dynamic environments. 
 4.  Experimental Section 
 Design and Fabrication Concept : Devices targeting large-scale 
culture applications are required to contain multiple samples for 
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 Figure 4.  a) Culture system apparatus. a1) Multiple culture devices connected to one single syringe pump for bidirectional perfusion. a2) Device 
being perfused with culture medium through silicone tubing connected to the lower medium inlet/outlet and with upper air inlets/outlets capped with 
fi lters. b) Procedure for retrieving the constructs from the culture device by manually breaking and cutting with the aid of sterile scissors and tweezers.
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simultaneous testing and handling. This is usually achieved by using 
versatile test platforms and by process automation. The device utilized 
in this study was designed to be modular and to allow for upscaling 
according to the number of scaffolds required. As a proof of concept, 
a device was designed to simultaneously accommodate eight cubical 
scaffolds (8 mm width) composed of 400 µm diameter struts 1.5 mm 
horizontally spaced in a 0–90° orientation. Device design was performed 
in 3Ds Max (Autodesk, USA) software and consisted of building 
individualized bioreactor chambers by placing 1 mm thick walls around 
each of the eight scaffolds, which were organized in a rectangular 
2 × 4 confi guration. The walls were positioned 1 mm from the scaffolds 
and were 10 mm taller than the scaffolds in order to create a reservoir 
for the culture medium. The top of every four chambers (in a square 
confi guration) was covered by a pyramidal structure ending in a 2 mm 
diameter outlet used for attaching sterile fi lters during subsequent cell 
culture. A symmetrical minifl uidic channel network connected to a 2 mm 
diameter inlet/outlet was designed for homogenously distributing the 
culture medium through the various individual chambers. 
 Fluid Flow Modeling : Computational fl uid dynamics was used to 
simulate the fl ow pattern of the media in various device architectures. 
The studied architectures differed in two main aspects: the use of 
either rectangular or chamfered chamber bottom corners and the use 
of either wide or narrow top inlets/outlets. Given the high complexity 
of the device, a simplifi ed model consisting of 2D sections was fi rst 
created in Design Modeler 13.0 software (Ansys, USA). The profi le 
corresponding to the section of an 8 mm wide cubic porous scaffold 
surrounded by a 10 mm wide bioreactor chamber was considered. The 
thickness of the simplifi ed section was 0.1 mm, while a converged free 
mesh was generated using automatic element selection. By applying a 
free mesh with maximum face size of 0.2 mm, it was possible to reach a 
detailed and accurate solution with mesh independence. The fl uid fl ow 
velocity profi les were calculated using Fluent 13.0 software within Ansys 
Workbench 13.0 platform (Ansys, USA). The pressure at the device’s 
outlets was assumed to be zero and the scaffold and the bioreactor 
chamber were considered rigid and impermeable. We assumed 
that the viscosity and the density of the culture media at 37 °C were 
 η = 1.45 × 10 −3 Pa.s and  ρ = 1000 kg m −3 , respectively. 
 Conversion, Slicing, and Prototyping of 3D Models : The device design 
displaying the most homogeneous fl uid fl ow pattern was selected 
for further experiments. The device's 3D model was then sliced and 
converted to a G-Code fi le. The volumes corresponding to the eight 
cubes to be converted to porous scaffolds were processed using the 
open source software Reprap (Online Reprap Community). The cubes 
were sliced into 0.27 mm layers composed of deposition path lines with 
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 Figure 5.  a) DNA content in noncoated and CaP-coated scaffolds after 24 h, 2 weeks and 4 weeks of culture. # shows statistically different values 
( p  < 0.05). b) MTT staining of coated and noncoated samples seeded with osteoblasts after 24 h, 2 and 4 weeks of culture. At the 4 weeks timepoint 
noncoated scaffolds struts were covered by a dense layer of single cells while CaP-coated scaffolds were covered by thick sheets of cells. White arrows 
indicate isolated adhered cells while black arrows indicate cellular bridging between struts.
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a spacing of 1.5 mm. On the contrary, the volume corresponding to the 
outer shell device was sliced and converted to G-Code fi les by using the 
open source software ReplicatorG (Online ReplicatorG Community). 
The conversion was performed using two shells, a slice thickness of 
0.27 mm, an object infi ll of 100%, a feed rate of 20 mm s –1 , and a travel 
feed rate of 55 mm s –1 as parameters. The G-Codes generated through 
RepRap and ReplicatorG were then merged together in order to generate 
one single G-Code fi le. The prototyping of the devices was performed 
using an open source dual extrusion rapid prototyping machine 
(Replicator, Makerbot Industries, USA). The materials used were 
 Figure 6.  SEM and confocal microscopy (right column) micrographs of noncoated and CaP-coated scaffolds seeded with osteoblasts after 24 h, 2 
and 4 weeks of culture. Samples observed through confocal microscopy were stained with FDA/PI showing live cells in green and dead cells in red.
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poly(lactic) acid (PLA) Ingeo 4043D (NatureWorks LLC, USA) for the 
porous scaffolds and acrylonitrile butadiene styrene (ABS) (Makerbot 
industries, USA) for the bioreactor chamber. The temperature used for 
fusing both materials in their corresponding nozzles was 220 °C. Both 
materials were deposited through coordinated and alternated operation 
of the nozzles. 
 Bioreactor Surface Treatment : In order to ensure that fl uid leakage could 
not occur during subsequent cell culture, a posttreatment coating of ABS 
was applied to the outer bioreactor wall surfaces to close any remaining 
porosity. In brief, after capping all inlets/outlets, the devices were immersed 
for 2 s in an ABS/acetone 60 mg mL –1 solution and then air-dried at room 
temperature for 30 min. This procedure was performed twice. Finally, the 
devices were washed in distilled water to remove residual solvent. 
 Scaffold Surface Treatment : Given the hydrophobic nature of PLA, 
which could hinder appropriate and homogeneous fl uid perfusion 
through the device, alkaline etching was performed using a 2  M NaOH 
solution. The devices were rinsed in 100% ethanol under vacuum for 
1 h to prewet the scaffold fi ber surfaces. After the removal of ethanol, 
NaOH solution was perfused through the device until the bioreactor 
was entirely fi lled. The devices were incubated for 30 min at room 
temperature under vacuum prior to a secondary incubation at 37 °C 
for 60 min. Finally, the devices were washed several times with distilled 
water and then air-dried prior to proceeding to the deposition of a 
calcium phosphate biomimetic coating on the PLA fi laments. 
 Biomimetic Coating of Scaffolds : The deposition of the calcium 
phosphate coating was performed by fi lling the chambers with a total 
of 8 mL of 10× SBF solution at pH 6 (solution preparation described 
elsewhere [ 18,21 ] ) for 30 min at 37 °C and followed by perfusion with a 
0.5  M NaOH solution for 30 min at 37 °C. Finally, the coated scaffolds 
were rinsed 5× with ultrapure water and air-dried. 
 Microcomputerized Tomography Analysis (MicroCT) : The devices 
were analyzed by MicroCT (µCT40, SCANCO Medical AG, Brüttisellen, 
Switzerland) at a resolution of 12 µm, a voltage of 55 kVp and at a 
current of 175 µA. 3D images were reconstructed from the scans by the 
microCT system software. 
 In Vitro Study : The cell-seeded scaffolds were cultured for up to 4 
weeks under bidirectional perfusion. To this end, a 1 mL sterile syringe 
was connected to each device's medium inlet using sterile silicone 
tubing. This apparatus was mounted on a multisyringe adapter placed 
on an Aladdin syringe pump (World Precision Instruments, USA). A 
total of 12 devices (each with a dedicated syringe) were simultaneously 
cultured in this system and therefore 96 scaffolds were cultured at one 
time. The devices were fi rst sterilized by perfusion with 50% ethanol 
solution for 20 min and dried in a sterile hood for 2 h. Each device 
was then manually fi lled with a total of 8 mL of basal medium and 
bidirectionally perfused overnight at a fl ow rate of 0.4 mL min –1 with 
fl ow inversion occurring every 100 s. This hydration step aimed to 
promote the preadsorption of proteins onto the scaffold and hence, 
facilitate subsequent cell attachment. In order to ensure the sterility of 
the device during the culture period while still allowing gas exchange 
with the incubator’s environment, 0.2 µm pore size fi lters (13-mm 
diameter) (Pall, USA) were connected to the outlets positioned at the 
top of the devices. Primary human osteoblasts were isolated from 
femur heads of patients undergoing hip surgery. Ethics approval for 
the use of human osteoblasts in this experiment was granted from 
the Prince Charles Hospital Ethics Committee (Ethics Clearance No.: 
EC2310) and Queensland University of Technology ethics committee 
(Ethics Clearance No.: 0600000232). The osteoblasts were expanded 
in basal alpha MEM-modifi ed medium (Gibco, USA) supplemented 
with 10% fetal calf serum and 1% penicillin/streptomycin and used 
at passage 2. When reaching confl uence, the cells were trypsinized 
and 250 µL cell suspensions containing 1 × 10 6 osteoblasts were 
injected into the devices through the silicone tube connecting the 
devices. Since the minifl uidic channel network diverted the fl uid into 
eight individual chambers, each scaffold was theoretically seeded with 
125 000 cells. The devices were bidirectionally perfused for 24 h at a 
fl ow rate of 0.4 mL min –1 (resulting in a 0.05 mL min –1 fl ow rate per 
chamber) in order to allow cell attachment. The perfusion direction was 
automatically inverted every 100 s utilizing an external microcontroller 
connected to the syringe pump. After 24 h, the culture medium 
was replaced with fresh medium and the fl ow rate was increased to 
0.8 mL min –1 (0.1 mL min –1 per chamber), whereas the fl ow inversion 
frequency was reduced to 50 s. The medium was changed weekly and 
the scaffolds were collected for further analysis at 24 h, 2 weeks and 4 
weeks postseeding. The scaffold collection was performed as follows: 
the devices were detached from the syringe pump by removing the 
silicone tubing and placed in a sterile biohazard safety cabinet. The 
scaffolds were retrieved from the interior of the bioreactor chambers by 
manually sectioning the bioreactor walls using scissors and tweezers. 
The collected scaffolds were processed for DNA content quantifi cation, 
MTT staining, live/dead assay, confocal laser, and scanning electron 
microscopy examination. 
 DNA Content Quantifi cation : For cellular DNA content analysis, 
the cell-scaffold constructs were frozen at –80°C for at least 48 h. The 
cell membrane and the extracellular matrix were disrupted in 300 µL 
of 0.5 mg mL –1 Proteinase K in phosphate buffered EDTA (PBE) at 
37 °C overnight and then transferred into 1.5 mL eppendorf tubes 
and further incubated for 24 h at 60 °C. 100 µL of the diluted (1/50 in 
PBE) lysate were aliquoted into black 96-well plates with 100 µL of 
PicoGreen (P11496, Invitrogen) working solution according to the 
manufacturer's instructions. After 5 min incubation in the dark, the 
fl uorescence (excitation 485 nm, emission 520 nm) was measured using 
a fl uorescence plate reader. A standard curve was also constructed using 
known concentrations of  λ DNA provided with the kit. The standards 
ranged from 10 ng mL –1 to 1 µg mL –1 λ DNA and were used to calculate 
the fi nal DNA content of the sample. 
 Metabolic Activity Staining : Metabolically, active cells were visualized 
by using a 1 mg mL –1 MTT solution. Following retrieval, the scaffolds 
were washed in PBS and then immersed into MTT solution for 30 min. 
Images were captured by a digital camera mounted on an Eclipse TS100 
microscope (Nikon, Tokyo, Japan). 
 Live/Dead Assay (FDA/PI) : Cell viability was assessed using a 
live/dead assay. For this purpose, the cell-scaffold constructs were 
washed twice in PBS, incubated for 5 min at 37 °C in PBS containing 
0.67 µg mL –1 fl uorescein diacetate (FDA) and 5 µg mL –1 propidium 
iodide (PI) (both Invitrogen) and washed again in PBS. The cellularized 
scaffolds were then analyzed using a confocal laser scanning microscope 
(Leica TCS SP5, Leica Microsystems, GmbH). The excitation/emission 
wavelengths used for imaging the FDA and PI stainings were 488/518–
568 and 561/598–795 nm, respectively. A semiquantitative analysis of 
the cellular viability was performed using ImageJ software to quantify 
living cells (green color) and dead cells (red color). At least two images 
from different areas (top and bottom) of the constructs were captured 
and analyzed for each condition/timepoint. 
 Scanning Electron Microscopy : Osteoblast morphology and distribution 
in the scaffolds was assessed at 24 h, 2 and 4 weeks postseeding by 
scanning electron microscopy. In brief, samples were fi xed in 3% 
glutaraldehyde, washed in 0.1  M cacodylate buffer, postfi xed in 1% 
osmium tetroxide in cacodylate buffer for 1 h, prior to dehydration 
through sequential graded series of ethanol concentrations. Finally, 
samples were immersed in hexamethyldisilazane for 60 min, air dried, 
mounted onto aluminum stubs, and gold coated. Samples were 
 Table 1.  Statistical analysis of percentage of live cellular content in CaP-
coated and noncoated constructs after 24 h, 2 and 4 weeks of culture. 
Values are not statistically different ( p  > 0.05) showing that the per-
centage of live cellular content is kept constantly high throughout the 4 
weeks culture period in both conditions. 
Culture period Noncoated 
[%]
Coated 
[%]
24 h 97.53 ± 4.28 93.64 ± 9.88
2 weeks 95.44 ± 6.34 96.80 ± 2.00
4 weeks 85.67 ± 8.22 94.73 ± 3.69
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observed on a FEI Quanta 200 Environmental SEM operating at 10 kV. 
Scaffolds without cells were gold coated prior to imaging. 
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 Supporting Information is available from the Wiley Online Library or 
from the author. 
 Acknowledgements 
 P.F.C. and D.W.H. contributed equally to this work. This work was 
supported by the Australian Research Council. P.F.C. acknowledges the 
Portuguese Foundation for Science and Technology for his PhD grant 
(SFRH/BD/62452/2009). 
Received:  September 25, 2014 
Revised:  January 8, 2015 
Published online:  
[1]  R.  Langer ,  J. P.  Vacanti ,  Science  1993 ,  260 ,  920 . 
[2]  a)  D. W.  Hutmacher ,  J. Biomater. Sci., Polym. Ed.  2001 ,  12 ,  107 ; 
 b)  I.  Martin ,  D.  Wendt ,  M.  Heberer ,  Trends Biotechnol.  2004 ,  22 ,  80 . 
[3]  D. A.  Pereira ,  J. A.  Williams ,  Br. J. Pharmacol.  2007 ,  152 ,  53 . 
[4]  a)  C. G. Simon  Jr. ,  J. S.  Stephens ,  S. M.  Dorsey ,  M. L.  Becker ,  Rev. 
Sci. Instrum .  2007 ,  78 ,  072207 ;  b)  P.  Zapata ,  J.  Su ,  A. J.  Garcia , 
 J. C.  Meredith ,  Biomacromolecules  2007 ,  8 ,  1907 ;  c)  M.  Nakajima , 
 T.  Ishimuro ,  K.  Kato ,  I. K.  Ko ,  I.  Hirata ,  Y.  Arima ,  H.  Iwata ,  Bio-
materials  2007 ,  28 ,  1048 ;  d)  D. R.  Albrecht ,  V. L.  Tsang ,  R. L.  Sah , 
 S. N.  Bhatia ,  Lab Chip  2005 ,  5 ,  111 ;  e)  C. G. Simon  Jr. ,  N.  Eidelman , 
 S. B.  Kennedy ,  A.  Sehgal ,  C. A.  Khatri ,  N. R.  Washburn ,  Bio-
materials  2005 ,  26 ,  6906 ;  f)  J.  Kohn ,  Nat. Mater.  2004 ,  3 ,  745 ; 
g)  D. G.  Anderson ,  S.  Levenberg ,  R.  Langer ,  Nat. Biotechnol.  2004 , 
 22 ,  863 . 
[5]  a)  E.  Cukierman ,  R.  Pankov ,  D. R.  Stevens ,  K. M.  Yamada ,  Science 
 2001 ,  294 ,  1708 ;  b)  T.  Sun ,  S.  Jackson ,  J. W.  Haycock ,  S.  MacNeil , 
 J. Biotechnol.  2006 ,  122 ,  372 ;  c)  A.  Birgersdotter ,  R.  Sandberg , 
 I.  Ernberg ,  Semin. Cancer Biol.  2005 ,  15 ,  405 ;  d)  D. W.  Hutmacher , 
 Nat. Mater.  2010 ,  9 ,  90 . 
[6]  a)  A.  Goncalves ,  P.  Costa ,  M. T.  Rodrigues ,  I. R.  Dias ,  R. L.  Reis , 
 M. E.  Gomes ,  Acta Biomater.  2011 ,  7 ,  1644 ;  b)  G. N.  Bancroft , 
 V. I.  Sikavitsast ,  J.  van den Dolder ,  T. L.  Sheffi eld ,  C. G.  Ambrose , 
 J. A.  Jansen ,  A. G.  Mikos ,  Proc. Natl. Acad. Sci. U.S.A.  2002 ,  99 , 
 12600 ;  c)  S. H.  Cartmell ,  B. D.  Porter ,  A. J.  Garcia ,  R. E.  Guldberg , 
 Tissue Eng.  2003 ,  9 ,  1197 ;  d)  A. S.  Goldstein ,  T. M.  Juarez , 
 C. D.  Helmke ,  M. C.  Gustin ,  A. G.  Mikos ,  Biomaterials  2001 , 
 22 ,  1279 ;  e)  W. L.  Grayson ,  S.  Bhumiratana ,  C.  Cannizzaro , 
 P. H. G.  Chao ,  D. P.  Lennon ,  A. I.  Caplan ,  G.  Vunjak-Novakovic , 
 Tissue Eng. Part A  2008 ,  14 ,  1809 ;  f)  Y. F.  Han ,  S. C.  Cowin , 
 M. B.  Schaffl er ,  S.  Weinbaum ,  Proc. Natl. Acad. Sci. U.S.A.  2004 , 
 101 ,  16689 ;  g)  D.  Marolt ,  A.  Augst ,  L. E.  Freed ,  C.  Vepari ,  R.  Fajardo , 
 N.  Patel ,  M.  Gray ,  M.  Farley ,  D.  Kaplan ,  G.  Vunjak-Novakovic , 
 Biomaterials  2006 ,  27 ,  6138 ;  h)  L.  Meinel ,  V.  Karageorgiou , 
 R.  Fajardo ,  B.  Snyder ,  V.  Shinde-Patil ,  L.  Zichner ,  D.  Kaplan , 
 R.  Langer ,  G.  Vunjak-Novakovic ,  Ann. Biomed. Eng.  2004 ,  32 ,  112 ; 
 i)  I.  Martin ,  T.  Smith ,  D.  Wendt ,  Trends Biotechnol .  2009 ,  27 ,  495 ; 
 j)  V. I.  Sikavitsas ,  G. N.  Bancroft ,  A. G.  Mikos ,  J. Biomed. Mater. 
Res .  2002 ,  62 ,  136 ;  k)  V. I.  Sikavitsas ,  G. N.  Bancroft ,  H. L.  Holtorf , 
 J. A.  Jansen ,  A. G.  Mikos ,  Proc. Natl. Acad. Sci. U.S.A.  2003 , 
 100 ,  14683 ;  l)  J.  van den Dolder ,  G. N.  Bancroft ,  V. I.  Sikavitsas , 
 P. H. M.  Spauwen ,  J. A.  Jansen ,  A. G.  Mikos ,  J. Biomed. Mater. 
Res. A  2003 ,  64A ,  235 ;  m)  M.  Frohlich ,  W. L.  Grayson ,  D.  Marolt , 
 J. M.  Gimble ,  N.  Kregar-Velikonja ,  G.  Vunjak-Novakovic ,  Tissue Eng. 
Part A  2010 ,  16 ,  179 . 
[7]  a)  S. J.  Hollister ,  Nat. Mater.  2005 ,  4 ,  518 ;  b)  F. P. W.  Melchels , 
 M. A. N.  Domingos ,  T. J.  Klein ,  J.  Malda ,  P. J.  Bartolo , 
 D. W.  Hutmacher ,  Prog. Polym. Sci.  2012 ,  37 ,  1079 ; 
 c)  D. W.  Hutmacher ,  S.  Cool ,  J. Cell. Mol. Med.  2007 ,  11 ,  654 ; 
d)  D. W.  Hutmacher ,  M.  Sittinger ,  M. V.  Risbud ,  Trends Biotechnol. 
 2004 ,  22 ,  354 ;  e)  R.  Grylls ,  Machine Design  2003 ,  75 ,  56 . 
[8]  P. F.  Costa ,  C.  Vaquette ,  J.  Baldwin ,  M.  Chhaya ,  M. E.  Gomes , 
 R. L.  Reis ,  C.  Theodoropoulos ,  D. W.  Hutmacher ,  Biofabrication 
 2014 ,  6 ,  035006 . 
[9]  a)  H. V.  Unadkat ,  M.  Hulsman ,  K.  Cornelissen ,  B. J.  Papenburg , 
 R. K.  Truckenmuller ,  G. F.  Post ,  M.  Uetz ,  M. J. T.  Reinders , 
 D.  Stamatialis ,  C. A.  van Blitterswijk ,  J.  de Boer ,  Proc. Natl. 
Acad. Sci. U.S.A.  2011 ,  108 ,  16565 ;  b)  M. P.  Lutolf ,  R.  Doyonnas , 
 K.  Havenstrite ,  K.  Koleckar ,  H. M.  Blau ,  Integr. Biol.  2009 ,  1 ,  59 ; 
 c)  Y.  Mei ,  Mater. Today  2012 ,  15 ,  444 . 
[10]  a)  M. J.  Jaasma ,  N. A.  Plunkett ,  F. J.  O’Brien ,  J. Biotechnol. 
 2008 ,  133 ,  490 ;  b)  F. W.  Janssen ,  J.  Oostra ,  A.  van Oorschot , 
 C. A.  van Blitterswijk ,  Biomaterials  2006 ,  27 ,  315 . 
[11]  L. A.  Hidalgo-Bastida ,  S.  Thirunavukkarasu ,  S.  Griffi ths , 
 S. H.  Cartmell ,  S.  Naire ,  Biotechnol. Bioeng.  2012 ,  109 ,  1095 . 
[12]  J. F.  Alvarez-Barreto ,  S. M.  Linehan ,  R. L.  Shambaugh , 
 V. I.  Sikavitsas ,  Ann. Biomed. Eng.  2007 ,  35 ,  429 . 
[13]  X.  Tian ,  S.  Wang ,  Z.  Zhang ,  D.  Lv ,  PLoS One  2012 ,  7 ,  e42804 . 
[14]  a)  E.  Figallo ,  C.  Cannizzaro ,  S.  Gerecht ,  J. A.  Burdick ,  R.  Langer , 
 N.  Elvassore ,  G.  Vunjak-Novakovic ,  Lab Chip  2007 ,  7 ,  710 ; 
 b)  M. Y.  Rotenberg ,  E.  Ruvinov ,  A.  Armoza ,  S.  Cohen ,  Lab Chip 
 2012 ,  12 ,  2696 . 
[15]  E.  Gottwald ,  S.  Giselbrecht ,  C.  Augspurger ,  B.  Lahni , 
 N.  Dambrowsky ,  R.  Truckenmuller ,  V.  Piotter ,  T.  Gietzelt ,  O.  Wendt , 
 W.  Pfl eging ,  A.  Welle ,  A.  Rolletschek ,  A. M.  Wobus ,  K. F.  Weibezahn , 
 Lab Chip  2007 ,  7 ,  777 . 
[16]  a)  J.  Yang ,  Y. Q.  Wan ,  C. F.  Tu ,  Q.  Cai ,  J. Z.  Bei ,  S. G.  Wang ,  Polym. 
Int.  2003 ,  52 ,  1892 ;  b)  H.  Tsuji ,  T.  Ishida ,  N.  Fukuda ,  Polym. Int. 
 2003 ,  52 ,  843 . 
[17]  A. L.  Oliveira ,  S. A.  Costa ,  R. A.  Sousa ,  R. L.  Reis ,  Acta Biomater . 
 2009 ,  5 ,  1626 . 
[18]  C.  Vaquette ,  S.  Ivanovski ,  S. M.  Hamlet ,  D. W.  Hutmacher ,  Biomate-
rials  2013 ,  34 ,  5538 . 
[19]  a)  M. T.  Arafat ,  C. X. F.  Lam ,  A. K.  Ekaputra ,  S. Y.  Wong ,  X.  Li , 
 I.  Gibson ,  Acta Biomater.  2011 ,  7 ,  809 ;  b)  J. V.  Araujo ,  A.  Martins , 
 I. B.  Leonor ,  E. D.  Pinho ,  R. L.  Reis ,  N. M.  Neves ,  J. Biomater. Sci., 
Polym. Ed.  2008 ,  19 ,  1261 . 
[20]  P. F.  Costa ,  C.  Vaquette ,  Q.  Zhang ,  R. L.  Reis ,  S.  Ivanovski , 
 D. W.  Hutmacher ,  J. Clin. Periodontol.  2014 ,  41 ,  283 . 
[21]  F.  Yang ,  J. G. C.  Wolke ,  J. A.  Jansen ,  Chem. Eng. J.  2008 ,  137 ,  154 . 
